Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28515431 | 0.90 | EPHX2 (0.37) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL25464053 | 0.89 | HPGD (0.40) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL28524385 | 0.82 | EPHX1 (0.50) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL30673977 | 0.82 | EPHX1 (0.54) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL30421849 | 0.79 | SSTR4 (0.41) | EPHX1KDM4EALDH1A1EPHX2 | |
| SCHEMBL12469141 | 0.77 | EPHX2 (0.42) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL24307260 | 0.74 | HPGD (0.44) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL14748226 | 0.74 | EPHX1 (0.54) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL29031342 | 0.74 | EPHX1 (0.48) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL20748429 | 0.72 | EPHX1 (0.52) | EPHX1NPC1SMN1; SMN2RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2268635-B1 | HETEROCYCLIC COMPOUNDS | TAIGEN BIOTECHNOLOGY CO LTD (TW) | 2015-06-10 | — | — | EP | disclosed |
| US-8372849-B2 | Heterocyclic compounds | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2013-02-12 | — | — | US | disclosed |
| US-8372849-B2 | Heterocyclic compounds | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2013-02-12 | — | — | US | disclosed |
| WO-2009131598-A1 | HETEROCYCLIC COMPOUNDS | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2009-10-29 | — | — | WO | disclosed |
| US-20090264339-A1 | Heterocyclic Compounds | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2009-10-22 | — | — | US | disclosed |
| US-20090264339-A1 | Heterocyclic Compounds | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264339-A1 | Heterocyclic Compounds | AHR, NQO1, LTC4S | EPHX1 105/4885NPC1 2663/4885SMN1; SMN2 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.